Akari Therapeutics, Plc
USD9.69
-1.04 (-9.69%)
CEO
Abizer Gaslightwala
IPO Date
2014-01-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$10.25
Prev. Close
$10.73
Day Low
$9.66
Day High
$11.51
52W Low
$3.02
52W High
$49.60
Market Cap
$0.01B
Volume
0.21M
| 1,395 |
| $9.32 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 1,570 | $8.28 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 2,539 | $5.12 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 3,725 | $3.49 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 7,353 | $3.74 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 1,000 | $13.00 |
| 25 Jun 2026 | Gaslightwala Abizer | director, officer: CEO | A-Award | Acquired | 5,500 | $4.64 |
| 25 Jun 2026 | Gaslightwala Abizer | director, officer: CEO | A-Award | Acquired | 15,563 | $14.63 |
| 16 Mar 2026 | Neal James R | director | P-Purchase | Acquired | 2,473 | $0.39 |